Researcher.Life Logo

CPT: Pharmacometrics and Systems Pharmacology : Impact Factor & More

eISSN: 2163-8306pISSN: 2163-8306
JournalOpen Access

Key Metrics

CiteScore
5
Eigenfactor
0.005 - 0.01
Impact Factor
< 5
SJR
Q1Pharmacology (medical)
SNIP
1.24
Recommended pre-submission checks
Powered by Paperpal by Editage

Topics Covered on CPT: Pharmacometrics and Systems Pharmacology

CPT: Pharmacometrics and Systems Pharmacology Journal Specifications

Indexed in the following public directories

  • Web of Science Web of Science
  • Scopus Scopus
  • DOAJ DOAJ
  • SJR SJR
Overview
Publisher WILEY
Language English
Frequency Monthly
Article Processing ChargesUSD 3000
Publication Time8
Editorial Review ProcessAnonymous peer review
General Details
LanguageEnglish
Society/Institute/SponsorAmerican Society for Clinical Pharmacology and Therapeutics (ASCPT)
FrequencyMonthly
Publication Start Year2012
Publisher URLVisit website
Website URLVisit website
Publication Details
Other chargesVisit website
Publication Time 8
Waiver PolicyVisit website
Editorial Review Detail
Editorial TeamVisit website
Review ProcessAnonymous peer review
Review UrlVisit website
Information for authors
Author instructionsVisit website
Deposit PolicySherpa/Romeo
License typeCC BY, CC BY-NC, CC BY-NC-ND
OA statementVisit website
View less

Planning to publish in CPT: Pharmacometrics and Systems Pharmacology ?

Upload your Manuscript to get

  • Degree of match
  • Common matching concepts
  • Additional journal recommendations
Free Report

Recently Published Papers in CPT: Pharmacometrics and Systems Pharmacology

Optimizing Venous Thromboembolism Prophylaxis in Burn Patients Using Enoxaparin Through PBPK Modeling.
  • 1 Jun 2026
  • CPT: pharmacometrics & systems pharmacology
Machine Learning Meets Pharmacokinetics: A Comparative Analysis of Predictive Models for Plasma Concentration-Time Profiles.
  • 1 May 2026
  • CPT: pharmacometrics & systems pharmacology
Title not available
  • 1 May 2026
  • CPT: Pharmacometrics &amp; Systems Pharmacology
Population Pharmacokinetics and Exposure-Response Analysis of Ziftomenib in Relapsed or Refractory Acute Myeloid Leukemia Patients With NPM1 Mutation.
  • 1 May 2026
  • CPT: pharmacometrics & systems pharmacology
Towards a Quantitative Understanding of Aficamten Clinical Pharmacology: Pharmacokinetic-Cardiodynamic Modeling to Support Safety and Efficacy.
  • 1 May 2026
  • CPT: pharmacometrics & systems pharmacology
Semi-Mechanistic PK/PD Modeling of Platelets and Spleen Volume With Navitoclax in Combination With Ruxolitinib in Patients With Myelofibrosis.
  • 1 May 2026
  • CPT: pharmacometrics & systems pharmacology
Optimizing Venous Thromboembolism Prophylaxis in Burn Patients Using Enoxaparin Through PBPK Modeling.
  • 1 Jun 2026
  • CPT: pharmacometrics & systems pharmacology
Machine Learning Meets Pharmacokinetics: A Comparative Analysis of Predictive Models for Plasma Concentration-Time Profiles.
  • 1 May 2026
  • CPT: pharmacometrics & systems pharmacology
Title not available
  • 1 May 2026
  • CPT: Pharmacometrics &amp; Systems Pharmacology
Population Pharmacokinetics and Exposure-Response Analysis of Ziftomenib in Relapsed or Refractory Acute Myeloid Leukemia Patients With NPM1 Mutation.
  • 1 May 2026
  • CPT: pharmacometrics & systems pharmacology
Towards a Quantitative Understanding of Aficamten Clinical Pharmacology: Pharmacokinetic-Cardiodynamic Modeling to Support Safety and Efficacy.
  • 1 May 2026
  • CPT: pharmacometrics & systems pharmacology
Semi-Mechanistic PK/PD Modeling of Platelets and Spleen Volume With Navitoclax in Combination With Ruxolitinib in Patients With Myelofibrosis.
  • 1 May 2026
  • CPT: pharmacometrics & systems pharmacology

FAQs on CPT: Pharmacometrics and Systems Pharmacology